First Half 2017 Results press release

Learn about the financial results of the first half of 2017 by downloading our press release published on July 26.


No votes yet
 
Related
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
Laboratorios Farmacéuticos Rovi, SA (BME: ROVI), company Pan-European pharmaceutical company specialized and dedicated to the research...
6 min
13/05/2021
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
29/04/2021